NYSE | TSX: ACB
EDMONTON, AB, June 16, 2020 /CNW/ - Aurora Cannabis Inc.
(the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB),
the Canadian company defining the future of cannabinoids worldwide,
today announced that Co-Founder Steve
Dobler, will retire from his roles as President and Director
of the Company, effective June 30,
2020. Mr. Dobler has been the President of Aurora and a
member of Aurora's Board of Directors since December 2014.
"On behalf of our Board of Directors and management team, I
would like to thank Steve for all his contributions to Aurora and
for his tenure as a director on our board," said Michael Singer, Executive Chairman and Interim
CEO of Aurora. "His keen business insight and unparalleled passion
for the company will be greatly missed. Steve's decision to retire
and help streamline our leadership team further supports the
objectives of our business transformation plan as we remain focused
on driving Aurora to become a profitable and robust global cannabis
With the retirement of Mr. Dobler, the board currently has nine
directors, seven of whom remain independent.
Aurora is a global leader in the cannabis industry serving both
the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in
global cannabis dedicated to helping people improve their lives.
The Company's brand portfolio includes Aurora, Aurora Drift, San
Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler,
and ROAR Sports. Providing customers with innovative, high-quality
cannabis products, Aurora's brands continue to break through as
industry leaders in the medical, performance, wellness and
recreational markets wherever they are launched. For more
information, please visit our website at www.auroramj.com.
Aurora's Common Shares trade on the TSX and NYSE under the
symbol "ACB", and is a constituent of the S&P/TSX Composite
View original content to download
SOURCE Aurora Cannabis Inc.